PRACTICE GUIDELINE FOR THE TREATMENT OF PATIENTS WITH OBSESSIVE-COMPULSIVE
DISORDER Page 1 Not for Distribution or Citation Draft 2, December 6, 2005 PRACTICE …

In this position statement, developed by The International College of Obsessive-Compulsive
Spectrum Disorders, a group of international experts responds to recent developments in the …

This revision of the 2005 British Association for Psychopharmacology guidelines for the
evidence-based pharmacological treatment of anxiety disorders provides an update on key …

Obsessive-compulsive disorder (OCD) can present a significant management challenge to
the clinical psychiatrist. OCD affects approximately 1.3% of the population in any given year …

Caffeine intake is so common that its pharmacological effects on the mind are undervalued.
Since it is so readily available, individuals can adjust their own dose, time of administration …

Serotonin reuptake inhibitor (SRI) medications are well established as first-line
pharmacotherapeutic treatment for Obsessive-Compulsive Disorder (OCD). However …

The basic concepts underlying compulsive, impulsive and addictive behaviours overlap,
which may help explain why laymen use these expressions interchangeably. Although there …

Objective: The market and degree of consumption of energy drinks have exponentially
expanded while studies that assess their psychological effects and impact on quality of life …

This narrative review gathers together a range of international experts to critically appraise
the existing trial-based evidence relating to the efficacy and tolerability of pharmacotherapy …

Knowledge of pharmacotherapeutic treatment options in obsessive-compulsive disorder
(OCD) has grown considerably over the past 40 years. Serotonergic antidepressants, such …